A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression
Open Access
- 1 March 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Pharmacogenomics Journal
- Vol. 2 (3), 191-196
- https://doi.org/10.1038/sj.tpj.6500099
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Patterns and predictors of remission, response and recoveryin major depression treated with fluoxetine or nortriptylineAustralian & New Zealand Journal of Psychiatry, 2002
- Age-related changes in vascular responsesExperimental Gerontology, 1999
- Drug-Induced Orthostatic Hypotension in the ElderlyDrug Safety, 1997
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.JCI Insight, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Drug-Induced Orthostatic HypotensionDrug Safety, 1991
- P-Glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistanceBiochemical and Biophysical Research Communications, 1989
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960